CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitusAndrew D. Vonberg(Diabetes Research Center), Massimo Pietropaolo(Baylor College of Medicine)JCI InsightDecember 5, 201810.1172/jci.insight.99860Cited by 8SaveCiteExport RISWatch citationsRelated PapersPrediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies|Diabetes|1996|794Late Progression to Diabetes and Evidence for Chronic β-Cell Autoimmunity in Identical Twins of Patients With Type I Diabetes|Diabetes|1995|103